Our History

Founded in 1998, AllCells is a biotechnology company dedicated to providing global researchers and biomanufacturing organizations with a dependable supply of biologically relevant, high quality primary cells that enable drug discovery, development, and manufacturing of cell therapies. Leveraging its expertise in hematology and immunology cell isolations, combined with on-site whole blood and bone marrow tissue collection operations, AllCells maintains direct access to a large repository of diverse donor profiles that can be further screened and qualified for biomedical applications. Utilizing its contiguous cell processing facilities, freshly collected tissue is immediately processed into purified cell types with unparalleled quality consistency. This optimal work-flow provides for the highest viability, purity, and cell count available. Fresh or frozen cells are shipped worldwide, or fresh cells can be immediately utilized in fee-for-service cell-based assays, AllCellutions™ – delivering cell culture results/data to meet client project timelines.

AllCells is grateful to our customers for their support over the past 19 years! We have grown by adapting to changing market trends to ensure we are anticipating and enhancing our offerings to our customers around the world. We are pleased to continue fulfilling your special requirements and look forward to working with you in the future!

The story of AllCells begins with our Founder and President, Dr. Jay Tong. After completing his training as a hematologist, Dr. Tong began a career as a research scientist in the early 90’s. While working at Novartis Systemics, he noticed a common pain-point amongst his peers: how to get starting materials for their projects? Many of them resorted to donating themselves or asking friends and family. Even with these substitutes they were never sure if they could get enough samples by the end of the day for their experiments. “Why is this such a frustrating process? Are there any commercial entities to help?” thought Dr. Tong. Before the time of internet searches, Dr. Tong asked around from colleagues and determining that no commercial sources existed, decided to do it himself. Read the full story here.

icon1

All the Right Cells.

Great results start with the right cells:

  • Broad catalog covering multiple cell types within hematology/immunology
  • Unsurpassed flexibility and customizability
  • Ability to run client-designed assays on fresh cells

Click to learn more.

time-icon

All the Time.

Great results depend on the right cells, all the time:

  • On-site blood and marrow tissue collection facilities ensure immediate access to our donor pool
  • On-time delivery based on customer’s research schedule
  • Around the world service through global distributors

Click to learn more.

guaranteed

All Ways Guaranteed.

The AllCells AAA Guarantee covers all the different ways you may customize your order with us by:

  • Always guaranteeing cell viability and quantity meet its product specifications
  • Always guaranteeing cell purity meets it’s product specification
  • Always guaranteeing customized orders are delivered as promised and specified by customers

Click here to learn more.

jaytongDr. Jay TongPresident & CEO

Jay Tong, M.D, founded AllCells, LLC in 1998 and has served as the company’s President & CEO since that time. While working as a Research Scientist at Novartis-Systemix (Palo Alto, CA) in the 1990s, Dr. Tong recognized an industry need for a readily available commercial source of hematologic tissue such as bone marrow, cord & peripheral blood, and purified hematology & immunology primary cell types needed to support scientific research, drug discovery and development.

Read more

team-linked-in-icon

View Profile
waynevazWayne Vaz Vice President of Corporate Development

Wayne Vaz, Vice President, Corporate Development, joined AllCells, LLC, in 2010 as a member of the executive team, responsible for commercial strategy and transforming the company into a market leader. Mr. Vaz has held executive positions in Canada and U.S covering areas of corporate business development, technology & alliance, technology roadmapping, strategic planning, M&A, market channel development, technical services, and quality assurance. 

Read more

team-linked-in-icon

View Profile
lewischapmanLewis P. ChapmanVice President, Global Commercial Operations

Lewis Chapman joined AllCells’ executive team January 11, 2016. Lewis is a seasoned Commercial Executive with over 30 years of experience in Marketing, Sales and Business Development at both small and large Life Science, Biopharmaceutical, and Medical Device companies. 

Read more

team-linked-in-icon

View Profile
robfrankenbergRob Frankenberg PhD, PMP, CPIM, CSCPVice President of Manufacturing Operations

Rob Frankenberg joined AllCells’ executive team June 20, 2016 as Vice President of Manufacturing Operations. Previously Rob was GMP Operations Manager at Bio-Rad Laboratories, Hercules, accountable for the operational leadership of Bio-Rad’s Northern California GMP clinical diagnostics consumables manufacturing operation representing >$250M in annual sales and a production team of 29 team members and 3 supervisors.

Read more

team-linked-in-icon

View Profile
tcfongTimothy C. Fong, PhD, MBAVice President, Science & Technology

Tim Fong joined the executive team March 16, 2017. Tim has over 20 years of biotech industry experience with broad expertise in therapeutic drug discovery and development. Tim has led teams in discovery research, preclinical studies, product characterization, and GMP manufacturing process development in several platform technologies, including cell and gene therapy, bio-active peptides and recombinant protein with a focus on cancer immunotherapy, angiogenesis, autoimmunity, and inflammatory diseases.

Read more

team-linked-in-icon

View Profile
tedparentiTed ParentiDirector, Finance

Ted Parenti, Director of Finance, joined AllCells LLC in May 2016. Mr. Parenti brings to AllCells extensive experience in cost accounting, capital investment and budget, and forecast/analysis using ERP systems. Ted has primary responsibility for leading the company’s accounting control, financial reporting, and forecasting processes.

Read more

team-linked-in-icon

View Profile
DonKlabundeDon KlabundeDirector, Enterprise Systems & IT

Don is a seasoned technology leader with a long track record of successfully leveraging technology to enable business success and has been a part of the AllCell’s team since early 2016. Don is highly experienced in technology solutions such as: ERP, CRM, E-commerce, Finance, Retail, Marketing and Supply Chain – across multiple vertical industries.

We love feedback from our customers! If our products/services have helped your experiments please share your story with us and let us know how we can better serve your needs in the future.

Human donors recruited through the clinical division of AllCells, LLC participated in a study involving the validation of the Spectra Optia® system for mononuclear cell (MNC) collection. The Spectra Optia ® system is a next-generation apheresis platform developed by Terumo BCT. The data generated from the study was submitted by Terumo BCT to the FDA in connection with the "510(k) clearance" and the release for commercial sale of this new apheresis technology within the USA.

- Terumo BCT
I have ordered the comprehensive RNA from AllCells, isolated from CD19+ B-cells. The product was of the highest quality, as assessed by the Agilent Bioanalyzer and was successfully used for qRT-PCR. I have also purchased a custom based order of cRNA and also DNA matched to the same 3 donors. The product was extremely competitively priced and shipped within 2 weeks of payment.

- Rachel Culpin from Newcastle University, United Kingdom
I have been working for 20 years with researchers that wants experiments done by yesterday. We are satisfied with AllCells frozen cell products.

- Maria Lopez from David Axelrod Institute
We had very good viability and were pleased with the quality of the Non-Hodgkin's Lymphoma cells we received last week.

- Ann Coulter, PhD., Esperance Pharmaceuticals, Inc.